Search

everythinglearnresearchcommunity

for

Search:↓

Hair analysis for drugs in psychosis patients is unreliable due to varying hair growth rates.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Botanical extracts and Minoxidil improved hair condition in a boy with a genetic disorder.

Topical tofacitinib is effective and safe for treating alopecia areata.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

PROTO1 and PROTO2 protect against hearing damage.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.